Dose emissions from marketed dry powder inhalers
Michael Hindle(Virginia Commonwealth University), Peter R. Byron(Virginia Commonwealth University Medical Center)
Cited by 107
Related Papers
Comparing MDI and DPI Aerosol Deposition Using In Vitro Experiments and a New Stochastic Individual Path (SIP) Model of the Conducting Airways
|Pharmaceutical Research|2012|185
Determination of the relative bioavailability of salbutamol to the lung following inhalation [see comments]
|British Journal of Clinical Pharmacology|1992|166
Use of computational fluid dynamics deposition modeling in respiratory drug delivery
|Expert Opinion on Drug Delivery|2018|142
Comparison of ambient and spray aerosol deposition in a standard induction port and more realistic mouth–throat geometry
|Journal of Aerosol Science|2008|127
<i>In Vivo–In Vitro</i> Correlations: Predicting Pulmonary Drug Deposition from Pharmaceutical Aerosols
|Journal of Aerosol Medicine and Pulmonary Drug Delivery|2010|115